Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 4,250.00
+190.00 (4.68%)
At close: Sep 11, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 35.22 billion as of September 11, 2026. Its market cap has increased by 4.62% in one year.
Market Cap
35.22B
Enterprise Value
34.13B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,250.00
ChartMarket Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 35.22B, a decrease of -70.29%. That is a compound annual growth rate of -20.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 35.22B | 25.93% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hironic | 63.25B |
| SELVAS Healthcare | 61.21B |
| DRGEM | 53.93B |
| QuantaMatrix | 48.73B |
| JPI Healthcare | 44.67B |
| Genoray | 42.14B |
| UXN Co., Ltd. | 31.26B |
| CU Medical Systems | 28.33B |